Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Urinary Bladder Neoplasms 4Sarcoma 2Prostatic Hyperplasia 1Pathologic Complete Response 1Paranasal Sinus Neoplasms 1Neoplasms 1Lung Neoplasms 1Estrogen Receptor Positive Breast Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Early Intervention, Educational 29Educational Status 28Blood Specimen Collection 28Standard of Care 26Methods 24Exercise 20Magnetic Resonance Spectroscopy 19Radiosurgery 18Surveys and Questionnaires 17Practice Guidelines as Topic 17X-Rays 16Tomography, X-Ray Computed 13Radiotherapy 11Biopsy 11Specimen Handling 10Interviews as Topic 10Fluorodeoxyglucose F18 10Patient Navigation 9Bronchoscopy 9Thoracic Surgery, Video-Assisted 8Therapeutics 8Saline Solution 7Psychiatric Rehabilitation 7Palliative Care 7Control Groups 7Acupuncture Therapy 7Drug Therapy 6Cryosurgery 6Counseling 6Breathing Exercises 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lung Neoplasms × Transurethral Resection of Bladder × Clear all
NCT00653250 2013-05-21

Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Vanderbilt-Ingram Cancer Center

Phase NA Completed
22 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡